Nuvation Bio director granted 123,397 stock options
Nuvation Bio Inc. director Kathryn E. Falberg received a grant of stock options covering 123,397 shares of Class A common stock at an exercise price of $4.79 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Nuvation Bio Inc. director Kathryn E. Falberg received a grant of stock options covering 123,397 shares of Class A common stock at an exercise price of $4.79 per share. The options vest 100% on the earlier of May 21, 2026 or the next shareholder annual meeting, subject to her continuous service, and expire on May 20, 2036. Following this award, she holds 123,397 derivative securities directly.
Insider Trade Summary
Grant/Award: 123,397 shares
Grant/Award
1 txn
Insider
FALBERG KATHRYN E
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 123,397 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 123,397 contracts (Direct)
Footnotes (1)
- F1. 100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (May 21, 2026); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date.
Key Figures
Option grant size: 123,397 options
Exercise price: $4.79 per share
Post-grant derivative holdings: 123,397 derivative securities
+3 more
6 metrics
Option grant size
123,397 options
Stock Option (Right to Buy) granted to director on May 21, 2026
Exercise price
$4.79 per share
Conversion or exercise price for Class A common stock
Post-grant derivative holdings
123,397 derivative securities
Total options held directly following the transaction
Vesting date trigger
May 21, 2026
100% vesting on earlier of this date or next annual meeting
Expiration date
May 20, 2036
Option award expiration date
Transaction price per option
$0.00
Grant/award acquisition, no cash paid for options
Key Terms
Stock Option (Right to Buy), Class A Common Stock, exercise price, expiration date, +2 more
6 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
Class A Common Stock financial
"underlying_security_title: Class A Common Stock"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
exercise price financial
"conversion_or_exercise_price: 4.7900"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-05-20T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
grant date financial
"one-year anniversary of the grant date (May 21, 2026)"
The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.
continuous service financial
"subject to the Reporting Person's continuous service through such applicable vesting date"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Nuvation Bio (NUVB) director Kathryn Falberg report in this Form 4?
Kathryn E. Falberg reported receiving a stock option grant for 123,397 shares of Nuvation Bio Class A common stock. The options were awarded as compensation, not bought in the open market, and give her the right to purchase shares at a fixed exercise price.
How many Nuvation Bio (NUVB) options were granted to Kathryn Falberg?
She was granted options on 123,397 underlying shares of Class A common stock. This entire amount represents a new award, and after the transaction she holds 123,397 derivative securities directly according to the Form 4 disclosure for this grant.
What is the exercise price of Kathryn Falberg’s Nuvation Bio (NUVB) stock options?
The stock options have an exercise price of $4.79 per share. This means she can buy Nuvation Bio Class A common stock at $4.79 for each optioned share once the options vest and before they reach their stated expiration date.
When do Kathryn Falberg’s Nuvation Bio (NUVB) options vest?
One hundred percent of the options vest on the earlier of May 21, 2026 or the next shareholder annual meeting. Vesting is conditioned on her continuous service through the applicable vesting date, as specified in the footnote to the Form 4 filing.
When do Kathryn Falberg’s Nuvation Bio (NUVB) options expire?
The options expire on May 20, 2036, giving a long-term window to exercise after vesting. After that expiration date, any unexercised options will lapse, and she will no longer have the right to purchase shares under this particular award.
Was Kathryn Falberg’s Nuvation Bio (NUVB) transaction a market purchase or sale?
The transaction was a grant of stock options, not a market purchase or sale. The Form 4 shows a transaction code "A" for a grant or award acquisition, with a transaction price per option of $0.00 and a fixed exercise price of $4.79 per share.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates